Radiation‑induced pure red cell aplasia combined with acquired amegakaryocytic thrombocytopenia in a thymoma after rapid response to radiotherapy: A case report and literature review

Xue,Yinyin; Wu,Qiang; Pu,Dan; Xu,Feng; Li,Yan

doi:10.3892/etm.2023.11936

Radiation‑induced pure red cell aplasia combined with acquired amegakaryocytic thrombocytopenia in a thymoma after rapid response to radiotherapy: A case report and literature review

Authors:
- Yinyin Xue
- Qiang Wu
- Dan Pu
- Feng Xu
- Yan Li
View Affiliations

Affiliations: Lung Cancer Center and Institute, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: April 4, 2023 https://doi.org/10.3892/etm.2023.11936
Article Number: 237
Copyright: © Xue et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Thymoma combined with pure red cell aplasia (PRCA) and acquired amegakaryocytic thrombocytopenia (AAMT) has been rarely reported, often occurring in the initial stage of treatment and after chemotherapy or thymectomy, while PRCA and AAMT occurring after radiotherapy for thymoma has not been reported. The present study describes the case of a 42‑year‑old female patient with thymoma complicated by radiation‑induced PRCA and AAMT after a rapid response to radiotherapy, who was in complete remission without recurrence after adjustment of initial symptomatic therapy to cyclosporine combined with prednisone. After 1 month, the patient underwent complete resection of mediastinal tumor. Next‑generation sequencing revealed that the DNA damage repair pathway‑related gene MSH3 was mutated, with p.A57P in abundance of 9.21%. To the best of our knowledge, the present study is the first to report that PRCA and AAMT secondary to thymoma after radiotherapy may be associated with increased sensitivity to radiotherapy caused by a mutation in the MSH3 gene.

View Figures

View References

1	Riedel RF and Burfeind WR Jr: Thymoma: Benign appearance, malignant potential. Oncologist. 11:887–894. 2006.PubMed/NCBI View Article : Google Scholar
2	Bernard C, Frih H, Pasquet F, Kerever S, Jamilloux Y, Tronc F, Guibert B, Isaac S, Devouassoux M, Chalabreysse L, et al: Thymoma associated with autoimmune diseases: 85 cases and literature review. Autoimmun Rev. 15:82–92. 2016.PubMed/NCBI View Article : Google Scholar
3	Rosenow EC III and Hurley BT: Disorders of the thymus. A review. Arch Intern Med. 144:763–770. 1984.PubMed/NCBI
4	Gay CM, William WN Jr, Wang SA and Oo TH: Thymoma complicated by acquired amegakaryocytic thrombocytopenia and pure red cell aplasia. J Natl Compr Canc Netw. 12:1505–1509. 2014.PubMed/NCBI View Article : Google Scholar
5	Dahal S, Sharma E, Dahal S, Shrestha B and Bhattarai B: Acquired amegakaryocytic thrombocytopenia and pure red cell aplasia in thymoma. Case Rep Hematol. 2018(5034741)2018.PubMed/NCBI View Article : Google Scholar
6	Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP and Oo TH: Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther. 12:115–118. 2019.PubMed/NCBI View Article : Google Scholar
7	Onuki T, Kiyoki Y, Ueda S, Yamaoka M, Shimizu S and Inagaki M: Invasive thymoma with pure red cell aplasia and amegakaryocytic thrombocytopenia. Hematol Rep. 8(6680)2016.PubMed/NCBI View Article : Google Scholar
8	Fujiwara A, Inoue M, Kusumoto H, Shintani Y, Maeda T and Okumura M: Myasthenic crisis caused by preoperative chemotherapy with steroid for advanced thymoma. Ann Thorac Surg. 99:e11–e13. 2015.PubMed/NCBI View Article : Google Scholar
9	Dragani M, Andreani G, Familiari U, Marci V and Rege-Cambrin G: Pure red cell aplasia and amegakaryocytic thrombocytopenia in thymoma: The uncharted territory. Clin Case Rep. 8:598–601. 2020.PubMed/NCBI View Article : Google Scholar
10	Maslovsky I, Gefel D, Uriev L, Ben Dor D and Lugassy G: Malignant thymoma complicated by amegakaryocytic thrombocytopenic purpura. Eur J Intern Med. 16:523–524. 2005.PubMed/NCBI View Article : Google Scholar
11	Cho AR, Cha YJ, Kim HR, Park EK and Cha EJ: Acquired amegakaryocytic thrombocytopenia after thymectomy in a case of pure red cell aplasia associated with thymoma. Korean J Lab Med. 30:244–248. 2010.PubMed/NCBI View Article : Google Scholar : (In Korean).
12	Thompson CA and Steensma DP: Pure red cell aplasia associated with thymoma: Clinical insights from a 50-year single-institution experience. Br J Haematol. 135:405–407. 2006.PubMed/NCBI View Article : Google Scholar
13	Andreassen CN, Alsner J, Overgaard M and Overgaard J: Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol. 69:127–135. 2003.PubMed/NCBI View Article : Google Scholar
14	Mangoni M, Bisanzi S, Carozzi F, Sani C, Biti G, Livi L, Barletta E, Costantini AS and Gorini G: Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys. 81:52–58. 2011.PubMed/NCBI View Article : Google Scholar
15	Terrazzino S, La Mattina P, Masini L, Caltavuturo T, Gambaro G, Canonico PL, Genazzani AA and Krengli M: Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery. Radiother Oncol. 103:199–205. 2012.PubMed/NCBI View Article : Google Scholar
16	Nogueira GAS, Costa EFD, Lopes-Aguiar L, Lima TRP, Visacri MB, Pincinato EC, Lourenço GJ, Calonga L, Mariano FV, Altemani AMAM, et al: Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients. Oncotarget. 9:29538–29547. 2018.PubMed/NCBI View Article : Google Scholar
17	Lopes-Aguiar L, Visacri MB, Nourani CML, Costa EFD, Nogueira GAS, Lima TRP, Pincinato EC, Moriel P, Altemani JMC and Lima CSP: Do genetic polymorphisms modulate response rate and toxicity of Cisplatin associated with radiotherapy in laryngeal squamous cell carcinoma?: A case report. Medicine (Baltimore). 94(e578)2015.PubMed/NCBI View Article : Google Scholar
18	Means RT Jr: Pure red cell aplasia. Blood. 128:2504–2509. 2016.PubMed/NCBI View Article : Google Scholar
19	Deeren D and Dorpe JV: Effective use of rituximab for acquired amegakaryocytic thrombocytopenia. Am J Hematol. 85:977–978. 2010.PubMed/NCBI View Article : Google Scholar
20	Chang H and Tang TC: Successful treatment of amegakaryocytic thrombocytopenia with azathioprine. Acta Haematol. 126:135–137. 2011.PubMed/NCBI View Article : Google Scholar